CANNAPHARMARX, INC. (OTC:CPMD)
Health Care/Life Sciences • Pharmaceuticals
CIK 1081938
Company
CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. It focuses on the treatment of disease states such as neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders, and ophthalmology. The company was founded in August 1998 and is headquartered in Calgary, Canada.
Address
888 3rd Street SW
Suite 3600
Calgary, Alberta T2P 5C5
888 3rd Street SW
Suite 3600
Calgary, Alberta T2P 5C5
Employees
6
6
Key Executives
Board Of Directors
President & Director Dominick Colvin |
Director Anthony Panek |
Director Adam Mindle |
Chairman Richard Dale Orman |
SEC filings
Date | Form | Event |
---|---|---|
3 Dec, 2024 | 8-K | |
21 Nov, 2024 | 8-K | |
14 Nov, 2024 | 10-Q | |
17 Sep, 2024 | 8-K | |
14 Aug, 2024 | 10-Q | |
25 Jun, 2024 | 10-Q | |
16 May, 2024 | 10-K | |
15 May, 2024 | NT 10-Q | |
27 Mar, 2024 | NT 10-K | |
22 Feb, 2024 | 8-K/A | |
16 Feb, 2024 | 8-K | |
6 Dec, 2023 | 8-K | |
17 Nov, 2023 | 10-Q | |
14 Nov, 2023 | NT 10-Q | |
13 Nov, 2023 | 8-K | |
13 Oct, 2023 | 10-Q | |
13 Oct, 2023 | 8-K | |
3 Oct, 2023 | 3 | |
22 Sep, 2023 | 10-Q | |
1 Sep, 2023 | 10-K | |
28 Aug, 2023 | 8-K | |
23 Jun, 2023 | 8-K | CEO Change |
30 Mar, 2023 | NT 10-K | |
21 Nov, 2022 | 10-Q | |
14 Nov, 2022 | NT 10-Q | |
4 Oct, 2022 | DEF 14A | |
26 Aug, 2022 | PRE 14A | |
22 Aug, 2022 | 10-Q | |
12 Aug, 2022 | NT 10-Q | |
11 Aug, 2022 | 424B3 | |
11 Aug, 2022 | EFFECT | |
9 Aug, 2022 | RW | |
9 Aug, 2022 | S-1/A | |
8 Aug, 2022 | S-1/A | |
8 Aug, 2022 | CORRESP | |
8 Aug, 2022 | UPLOAD | |
1 Aug, 2022 | S-1 | |
23 May, 2022 | 10-Q | |
16 May, 2022 | NT 10-Q | |
15 Apr, 2022 | 10-K | |
31 Mar, 2022 | NT 10-K | |
16 Feb, 2022 | 8-K | |
15 Nov, 2021 | 10-Q | |
16 Aug, 2021 | 10-Q | |
16 Jul, 2021 | 8-K | |
22 Jun, 2021 | 8-K | |
11 Jun, 2021 | EFFECT | |
10 Jun, 2021 | 424B3 | |
9 Jun, 2021 | 8-K | |
9 Jun, 2021 | CORRESP | |
26 May, 2021 | CORRESP | |
26 May, 2021 | S-1/A | |
24 May, 2021 | UPLOAD | |
17 May, 2021 | 10-Q | |
14 May, 2021 | S-1 | |
4 May, 2021 | EFFECT | |
3 May, 2021 | POS AM | |
28 Apr, 2021 | CORRESP | |
23 Apr, 2021 | UPLOAD | |
21 Apr, 2021 | CORRESP | |
21 Apr, 2021 | POS AM | |
20 Apr, 2021 | UPLOAD | |
15 Apr, 2021 | POS AM | |
14 Apr, 2021 | 10-K | |
1 Apr, 2021 | NT 10-K | |
28 Jan, 2021 | 8-K | |
25 Jan, 2021 | EFFECT | |
22 Jan, 2021 | 8-K | |
20 Jan, 2021 | 424B3 | |
19 Jan, 2021 | CORRESP | |
15 Jan, 2021 | S-1/A | |
12 Jan, 2021 | 8-K | |
18 Dec, 2020 | CORRESP | |
15 Dec, 2020 | UPLOAD |
Last update:2024-03-06 12:25:39.341644
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.